TMPA-AMPK Activator - CAS# 1258275-73-8 size:10mg solid Crenolanib has 25-fold more affinity

Crenolanib has 25-fold more affinity for PDGFRA/B compared with KIT

indicating that cycling populations of normal cells induce Chk1 pS345 following exposure to MK-8776 S-isomer as part of a futile cycle

It is found to be not stable at basic buffer

InChi: InChI=1S/C24H27N5O2/c1-2-31-23(30)10-14-26-21-17-22(28-24(27-21)20-9-5-6-13-25-20)29-15-11-18-7-3-4-8-19(18)12-16-29/h3-9

TMPA-AMPK Activator - CAS# 1258275-73-8 size:10mg solid Crenolanib has 25-fold more affinityTMPA, CAS No. 1258275 73 8, is a novel small molecule that binds to orphan Nuclear Receptor Nur77 with high affinity (Kd = 1. 45 0. 35 M), and interferes with the Nur77 LKB1 interaction. TMPAs binding to Nur77 results in the release and shuttling of LKB1 to the cytoplasm to phosphorylate AMPK. TMPA treatment can effectively reduce blood glucose and alleviate insulin resistance in type II db db and high fat diet and streptozotocin induced diabetic mice